Inspire Medical Systems, Inc. Stock 12‑Month Price Target Raised to $69.31, Implies 3% Upside
Inspire Medical Systems' average stock price target increased from $68 to $69.31 by 16 analysts, implying 3% upside from Nov. 2 close. 19 analysts maintain 'Hold' consensus, with 4 'Buy' and 4 'Sell' ratings.
How this was made

The 30-second read
Why it matters
A small increase in the average price target suggests incremental optimism, but the consensus rating staying at Hold implies limited immediate re-positioning.
Market read
Useful for tracking sentiment and target drift, but not a standalone catalyst for trading decisions.
What to watch
Because the article provides no new clinical, regulatory, or financial datapoint, traders may treat it as noise versus upcoming company-specific catalysts.
Background
The piece summarizes FactSet-derived consensus analyst targets and ratings for Inspire Medical Systems.
Ticker impact
Inspire Medical Systems’ average analyst price target rose from $68 to $69.31, with consensus rating still “Hold.”
Likely mild support as traders price in slightly higher targets, but follow-through may be capped by the unchanged Hold rating.
This is an analyst-target update without new company fundamentals, and the consensus remains Hold despite some Buys and Sells.
Market effects
Limited read-through to medical device peers because the update is purely analyst-target related, not a sector catalyst.
No clear regional spillover implied.
No global macro or cross-market linkage indicated.
Counterpoint
The higher average target may reflect dispersion (range $40 to $97) rather than a coherent re-rating, so price may not follow.
Key entities
- companyInspire Medical Systems, Inc.
Subject of the article, with average analyst price target raised to $69.31 and consensus rating remaining Hold.



